SCHEMBL5261579

SCHEMBL5261579

CC(=NOCc1ccccc1)C(C)Oc1ccccc1NC(=O)c1cccnc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.46
POLB P06746 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
GAA P10253 2/20 0.42
SGMS2 Q8NHU3 2/20 0.41
BRD4 O60885 1/20 0.41
PPIA P62937 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
ALDH1A1 P00352 1/20 0.40
RXFP1 Q9HBX9 2/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5263400 0.82 TDP1 (0.53) LMNAPOLBTDP1L3MBTL1GAA
SCHEMBL14880230 0.73 RAB9A (0.63) POLBTDP1L3MBTL1GAASMN1; SMN2
SCHEMBL31187261 0.69 POLB (0.67) LMNAPOLBTDP1L3MBTL1GAA
SCHEMBL5665605 0.69 RAB9A (0.47) POLBTDP1L3MBTL1GAASMN1; SMN2
SCHEMBL5665607 0.69 RAB9A (0.47) POLBTDP1L3MBTL1GAASMN1; SMN2
SCHEMBL28350930 0.68 TP53 (0.63) LMNAPOLBTDP1L3MBTL1PPIA
SCHEMBL3066338 0.68 GAA (0.54) LMNAPOLBTDP1L3MBTL1GAA
SCHEMBL8299753 0.68 TDP1 (0.68) LMNAPOLBTDP1L3MBTL1GAA
SCHEMBL7852351 0.67 TDP1 (0.61) TDP1L3MBTL1GAASMN1; SMN2MEN1
SCHEMBL28589136 0.67 POLB (0.64) LMNAPOLBL3MBTL1GAASGMS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1699752-B1 (HETERO)CYCLYL CARBOXANILIDES FOR CONTROLLING HARMFUL FUNGI BASF AG (DE) 2007-09-26 EP disclosed
US-20070117852-A1 (Hetero)cyclyl carboxanilides for controlling harmful fungi BASF AKTIENGESELLSCHAFT (DE) 2007-05-24 US disclosed
EP-1699752-A1 (HETERO)CYCLYL CARBOXANILIDES FOR CONTROLLING HARMFUL FUNGI BASF AKTIENGESELLSCHAFT (DE) 2006-09-13 EP disclosed
WO-2005063692-A1 (HETERO)CYCLYL CARBOXANILIDES FOR CONTROLLING HARMFUL FUNGI BASF AKTIENGESELLSCHAFT (DE) 2005-07-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070117852-A1 (Hetero)cyclyl carboxanilides for controlling harmful fungi CYCS, CBR3, CYC1 LMNA 4093/4885POLB 3992/4885TDP1 3248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.